Lyell Immunopharma
LYEL
#8241
Rank
NZ$0.31 B
Marketcap
$1.08
Share price
-4.41%
Change (1 day)
-67.82%
Change (1 year)

Market capitalization of Lyell Immunopharma (LYEL)

Market cap: NZ$0.31 Billion

As of December 2024 Lyell Immunopharma has a market cap of NZ$0.31 Billion. This makes Lyell Immunopharma the world's 8241th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lyell Immunopharma from 2021 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$0.31 B-59.02%
2023NZ$0.77 B-43.3%
2022NZ$1.36 B-49.99%
2021NZ$2.72 B

End of Day market cap according to different sources

On Dec 22nd, 2024 the market cap of Lyell Immunopharma was reported to be:

NZ$0.30 Billion
by Nasdaq info icon info icon
NZ$0.31 Billion
by CompaniesMarketCap info icon info icon